Literature DB >> 9506906

Endothelins--vasoactive peptides and growth factors.

M Stjernquist1.   

Abstract

The endothelins (ETs) are regulatory peptides, distributed in many organ systems and with potent physiological effects. ETs represent the most powerful vasoconstrictive substances known today. They also act as growth factors and seem to be involved in fetal development. Much data support a pathophysiological role for ETs, especially in diseases of the vascular system, such as hypertension, preeclampsia, ischemic heart disease, subarachnoidal haemorrhage, and cerebral ischemia. The development of drugs affecting ET-receptors and the biosynthesis of ETs presently attract great interest for the establishment of new treatments of diseases in which ETs are involved. Hopefully, the elaboration of more specific ET-receptor ligands will fulfill some of these expectations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506906     DOI: 10.1007/s004410051028

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  2 in total

1.  Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme.

Authors:  Wen-Tsong Hsieh; Wei-Lan Yeh; Ruo-Yuo Cheng; Chingju Lin; Cheng-Fang Tsai; Bor-Ren Huang; Caren Yu-Ju Wu; Hsiao-Yun Lin; Shiang-Suo Huang; Dah-Yuu Lu
Journal:  J Neurooncol       Date:  2014-04-23       Impact factor: 4.130

2.  The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification.

Authors:  M Cemazar; I Wilson; V E Prise; K M Bell; S A Hill; G M Tozer
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.